Results 221 to 230 of about 143,755 (261)
Some of the next articles are maybe not open access.

Pharmacology of Anticoagulants

Disease-a-Month, 2012
Antithrombotic drugs are used for the prevention and treatment of thrombosis. Targeting the various components of thrombosis, these agents include (1) antiplatelet agents; (2) anticoagulants; and (3) fibrinolytic agents. This review focuses on anticoagulants.
Loke, Chandravathi, MD   +2 more
openaire   +2 more sources

Anticoagulation in Pregnancy

Cardiology Clinics, 2012
Pregnancy-associated thrombosis is an important cause of morbidity and mortality during pregnancy. Anticoagulation therapy is an important component of the management of thrombotic complications in pregnancy but may result in fetal and maternal complications.
Sorel, Goland, Uri, Elkayam
openaire   +2 more sources

Anticoagulation Monitoring

Clinics in Laboratory Medicine, 2009
This article reviews the commonly used anticoagulants (warfarin and heparin) and associated recommended laboratory testing. Emphasis is on the various modes of International Normalized Ratio testing and associated variability (clinical laboratory, point of care, patient self-testing).
openaire   +2 more sources

The Anticoagulated Patient

Regional Anesthesia: The Journal of Neural Blockade in Obstetrics, Surgery, & Pain Control, 1996
The expanded role for antiplatelet drugs and anticoagulant therapy has resulted in more surgical patients receiving these medications during the perioperative period. The risk of developing a spinal hematoma (epidural, subdural, or subarachnoid) remains exceedingly small in most patients despite receiving these therapies.
openaire   +2 more sources

Anticoagulants and Anticoagulation

Medical Clinics of North America, 1976
M, Nussbaum, C B, Moschos
openaire   +2 more sources

Anticoagulant Thrombins

Trends in Cardiovascular Medicine, 1998
Thrombin plays both procoagulant and anticoagulant roles in the blood coagulation cascade. This dual role is influenced allosterically by the binding of Na(+) near the primary specificity pocket of the enzyme. Recent findings demonstrate that it is possible to engineer recombinant thrombins that have practically lost anticoagulant activity but retain ...
openaire   +2 more sources

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

New England Journal of Medicine, 2021
Marlene Santos   +2 more
exaly  

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

New England Journal of Medicine, 2021
Marlene Santos   +2 more
exaly  

ANTICOAGULANTS

Medical Journal of Australia, 1956
openaire   +2 more sources

Home - About - Disclaimer - Privacy